CIBC raised the firm’s price target on Thomson Reuters (TRI) to $201 from $174 and keeps a Neutral rating on the shares. The firm views Thomson Reuters’ revenue growth profile as attractive vs. peers. The company exited Q1 with a strong balance sheet and leverage of 0.6-times, with upside from M&A and its strong GenAI product roadmap. CIBC stays on the sidelines given current valuation, trading near the top end of its peer group range.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TRI:
- Thomson Reuters price target raised to $240 from $225 at UBS
- Thomson Reuters to join Nasdaq-100 Index on July 28
- Thomson Reuters price target raised to C$308 from C$280 at BMO Capital
- Thomson Reuters: Strong Market Position and Growth Potential with Strategic Focus on GenAI and Resilient Revenue Base
- Thomson Reuters price target raised to C$305 from C$260 at TD Securities